Profile
Björn A.
Ekberg worked as a Manager-Research & Development at LifeAssays AB and as a Chief Scientific Officer at Chempaq A.
He obtained a doctorate degree from the University of Lund in 1988.
Former positions of Björn A. Ekberg
Companies | Position | End |
---|---|---|
Chempaq A/S
Chempaq A/S Medical SpecialtiesHealth Technology Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product. | Chief Tech/Sci/R&D Officer | 2011-08-02 |
LIFEASSAYS AB (PUBL) | Chief Tech/Sci/R&D Officer | - |
Training of Björn A. Ekberg
University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
LifeAssays AB
LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
Chempaq A/S
Chempaq A/S Medical SpecialtiesHealth Technology Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product. | Health Technology |
- Stock Market
- Insiders
- Björn A. Ekberg